A convertible nephroureteral catheter is used in the treatment of urinary system complications, particularly on the need for a single surgically delivered device to treat patients who must be seen by an interventional radiologist (IR). In many current procedures, patients need to return to the operating room to remove a previously delivered nephroureteral catheter to exchange this catheter with a fully implanted ureteral stent delivered though the same access site at the flank. The present convertible nephroureteral catheter reduces the need to return for a second surgical procedure. Two weeks after initial implantation, the proximal portion of the convertible nephroureteral catheter extending out from the body may simply be removed. A simple action at the catheter hub allows this proximal portion to be removed, leaving behind the implanted ureteral stent within the patient's urinary system. Other medical procedures, devices, and technologies may benefit from the described convertible catheter.

An implantable biocompatible expander suitable for implantation into a urinary duct, comprises an elongated sinusoidal ring comprising at least two proximal prongs and at least two distal prongs, wherein the expander is resiliently deformable from a relaxed radially expanded orientation to a radially contracted orientation suitable for transluminal delivery through the urinary duct. The expander is configured to exert an outward radial force against a wall of the urinary duct when in-situ within the urinary duct. In particular, the expander is suitable for treatment of benign prostatic hyperplasia and configured for implantation into the prostatic urethra between, and substantially spanning the prostatic urethra between, the bladder neck and external sphincter.

A stent insertion device for connecting human digestive organs includes a first handle being connected to one side of an outer tube, the first handle including a first inner passage communicating with the outer tube, a second handle being connected to a first side of an inner tube, the second handle including a second inner passage communicating with the inner tube, wherein a mounting space is provided between the outer tube and the inner tube at a second side of the inner tube, a stent for connecting human digestive organs being compressed and mounted to the mounting space, a third handle being connected to a first side of an insulation tube, the third handle including a third inner passage communicating with the insulation tube, and a needle knife being connected to a second side of the insulation tube.

An apparatus including a first layer, where the first layer includes a scaffold structure forming an inner lumen along a length of the scaffold structure, and where the first layer includes a bioresorbable material; and a second layer on the first layer, where the second layer includes a bioresorbable material, where the second layer surrounds a majority of the first layer, and where the second layer is configured to hydroscopicly swell.

Systems, instruments, methods, and compositions are described involving removing a portion of the epidermis within a donor site on a subject, and harvesting dermal plugs within the donor site. An injectable filler is formed by mincing the dermal plugs. The injectable filler is configured for injecting into a recipient site on the subject.

The invention relates to a detection system of an endo-urethral device for an artificial urinary sphincter implantable in the body of a patient, said sphincter comprising an occlusive cuff (2) adapted to compress the urethra, the bladder neck or the prostate of said patient, an activation device (5) of said cuff (2) and a control unit (6) adapted to control the activation device.

Said system comprises at least one compression sensor (13) of the urethra and a posture sensor (9), and a processing unit (30) configured to determine: (i) if the compression parameter of the urethra exceeds a predetermined threshold during a predetermined period, (ii) if the patient is in a recumbent position.

If the conditions (i) and (ii) are fulfilled, the processing unit sends to the activation device (5) an immediate reduction order of the compression exerted by the cuff (2).

Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of implants are disclosed where the implants can have an elastic main body that is biased towards an at-rest configuration where the body forms multiple expander sections coupled together by interconnect portions. The expander sections can have numerous different shapes and configurations.

An implantable biocompatible expander suitable for implantation into a urinary duct, comprises an elongated sinusoidal ring comprising at least two proximal prongs and at least two distal prongs, wherein the expander is resiliently deformable from a relaxed radially expanded orientation to a radially contracted orientation suitable for transluminal delivery through the urinary duct. The expander is configured to exert an outward radial force against a wall of the urinary duct when in-situ within the urinary duct. In particular, the expander is suitable for treatment of benign prostatic hyperplasia and configured for implantation into the prostatic urethra between, and substantially spanning the prostatic urethra between, the bladder neck and external sphincter.

Urologic stents that are adapted for temporary use to provide relief following treatments for benign prostatic hyperplasia and other disorders of the prostate, urethra and ureters.

A medical device is disclosed for delivering a medical member which is intended to indwell in a treatment site of a urethra includes a flexible main body that extends in an axial direction, a balloon that includes an effectively dilatable portion on which the medical member is mounted, that has a dilating space into which a pressurizing medium flows between an outer surface of the main body and the balloon, and that is capable of dilating deformation and deflating deformation, an elongated guide member that is arranged across the treatment site and the outside of a living body via the urethra, and an attachment portion to which at least a portion of the guide member is detachably attached at a position between both end portions in the axial direction of the main body.